Factors associated with time until metastatic spread in patients with primary uveal melanoma: A retrospective analysis
- 1Department of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Austria.
- 0Department of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Austria.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Thicker choroidal or ciliary body melanoma and older patient age at diagnosis are linked to earlier metastasis. This study identifies key factors influencing melanoma progression time.
Area Of Science
- Ophthalmology
- Oncology
- Medical Research
Background
- Choroidal and ciliary body melanoma are rare eye cancers.
- Understanding metastasis risk factors is crucial for patient outcomes.
Purpose Of The Study
- To identify factors associated with the time to metastasis in patients with choroidal or ciliary body melanoma.
- To characterize these identified factors in detail.
Main Methods
- A mixed-effects model was employed to analyze patient data.
- Parameters and patient characteristics linked to metastatic events were identified and characterized.
Main Results
- Tumor thickness and patient age at diagnosis were significantly associated with time to metastasis.
- In 383 patients, thicker melanomas and older age correlated with earlier metastatic events.
- Other factors like sex, tumor dimensions, and therapy type showed no significant association.
Conclusions
- Primary tumor thickness is a significant predictor of earlier metastasis in choroidal and ciliary body melanoma.
- Patient age at diagnosis is also associated with the time until metastatic events.
- This research refines understanding of melanoma metastasis timelines.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

